dipyridamole has been researched along with 6-ketoprostaglandin f1 alpha in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (73.91) | 18.7374 |
1990's | 6 (26.09) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuta, K; Hattori, T; Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y | 1 |
Belch, JF; Fisher, TC; Forbes, CD; McLaren, M; Saniabadi, AR | 1 |
Bastiano, ML; Bisacci, R; Boschetti, E; Cipolloni, S; Costantini, V; Nenci, GG; Talpacci, A | 1 |
Aza, MJ; Castellarnau, C; Collado, PS; Gonzalez, J; Lasierra, J; Melon, J; Rutllant, M; Vazquez, E | 1 |
Cronenwett, JL; Huntsman, WT; McDaniel, MD; Miett, TO | 1 |
Bakhle, YS; Pankhania, JJ | 1 |
Benak, A; Christakis, GT; Ivanov, J; Levitt, D; Madonik, MM; Mee, AV; Reilly, P; Teoh, KH; Weisel, RD; Wong, PY | 1 |
Lüthy, C; Odavic, R; Oetliker, O; Siegrist, M | 1 |
Cloarec, M; Fenollar, JV; Kahn, M; Schram, E; Sneppe, R; Solvay, H; Van De Merckt, J | 1 |
Eisert, WG; Eldor, A; Fuks, Z; Muller, TH; Vlodavsky, I | 1 |
Donovan, DL; Evancho, MM; Hirko, MK; Hunter, TJ; Schmidt, SP; Sharp, WV | 1 |
Arnout, J; Deckmyn, H; Gresele, P; Vermylen, J; Zoja, C | 1 |
Blasevich, M; Borghi, A; Galli, C; Petroni, A; Socini, A | 1 |
Gershlick, AH; Lewis, CT; Mills, PG; Murday, AJ; Syndercombe Court, YD | 1 |
Gurewich, V; Louie, S | 1 |
Geling, NG; Giessler, C; Mentz, P; Orlowa, ZR; Pawelski, KE; Taube, C | 1 |
Puustinen, T; Uotila, P | 1 |
Cremer, KF; Joyal, M; Mehta, J; Pieper, JA | 1 |
Kärkölä, P; Pokela, R; Viinikka, L; Ylikorkala, O | 1 |
Bult, H; Herman, AG; Van de Velde, VJ | 1 |
Bearn, PE; Bull, H; Marston, A; McCollum, CN; Seddon, AM | 1 |
De la Cruz, JP; García Campos, JM; Moreno, A; Muñoz, M; Sánchez de la Cuesta, F | 1 |
Filinger, EJ; Peredo, HA | 1 |
3 trial(s) available for dipyridamole and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Dipyridamole; Double-Blind Method; Drug Synergism; Epoprostenol; Erythrocyte Deformability; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 1991 |
Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arachidonic Acid; Arachidonic Acids; Dipyridamole; Drug Synergism; Epoprostenol; Female; Humans; Male; Middle Aged; Organ Culture Techniques; Stimulation, Chemical; Veins | 1990 |
Blood conservation with membrane oxygenators and dipyridamole.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Blood; Blood Platelets; Clinical Trials as Topic; Contraceptives, Oral, Combined; Coronary Artery Bypass; Dipyridamole; Hemoglobins; Hemorrhage; Humans; Leukocyte Count; Middle Aged; Oxygenators; Oxygenators, Membrane; Platelet Count; Platelet Factor 4; Postoperative Complications; Prospective Studies; Random Allocation; Thromboxane B2 | 1987 |
20 other study(ies) available for dipyridamole and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Studies on the antinephritic effect of plant components (4): Reduction of protein excretion by berberine and coptisine in rats with original-type anti-GBM nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Berberine; Cholesterol; Creatinine; Dipyridamole; Drug Evaluation, Preclinical; In Vitro Techniques; Male; Nephritis; Plant Extracts; Platelet Aggregation; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Thromboxane B2 | 1992 |
Spontaneous atherosclerotic lesions and prostacyclin formation in rabbits: effects of combined dipyridamole and aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteries; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Rabbits | 1989 |
Effect of a selective thromboxane synthase inhibitor on arterial graft patency and platelet deposition in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arteries; Aspirin; Benzofurans; Blood Platelets; Blood Vessel Prosthesis; Carotid Arteries; Dipyridamole; Dogs; Female; Indium; Polyethylene Terephthalates; Polytetrafluoroethylene; Radioisotopes; Random Allocation; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Drug effects on output of prostacyclin from isolated lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Dipyridamole; Epoprostenol; Guinea Pigs; In Vitro Techniques; Lung; Male; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains | 1987 |
Effects of dipyridamole on prostaglandin synthesis in human fibroblasts.
Topics: 6-Ketoprostaglandin F1 alpha; Bradykinin; Cells, Cultured; Child, Preschool; Dipyridamole; Epoprostenol; Fibroblasts; Humans; Male; Prostaglandins; Stimulation, Chemical; Thromboxanes | 1987 |
Platelet hyperaggregability, blood prostacyclin and dipyridamole.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteriosclerosis; Binding Sites; Dipyridamole; Drug Administration Schedule; Epoprostenol; Erythrocytes; Female; Humans; Male; Middle Aged; Platelet Aggregation | 1986 |
Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cattle; Cells, Cultured; Dipyridamole; Endothelium; Epoprostenol; Extracellular Matrix; Humans; Models, Biological; Platelet Aggregation; Pyridazines; Thromboxanes | 1986 |
Endothelial cell seeding improves 4 mm PTFE vascular graft performance in antiplatelet medicated dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Dogs; Endothelium; Graft Occlusion, Vascular; Graft Survival; Male; Microscopy, Electron; Polytetrafluoroethylene; Vascular Patency | 1987 |
Lack of synergism between dazoxiben and dipyridamole following administration to man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Dipyridamole; Drug Synergism; Humans; Imidazoles; Male; Oxidoreductases; Platelet Aggregation; Thromboxane-A Synthase | 1985 |
Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-keto-PGF1 alpha in rat brain.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Brain; Dipyridamole; Male; Microwaves; Nifedipine; Papaverine; Rats; Thromboxane B2; Thromboxanes; Vasomotor System | 1985 |
Adverse effects of high dose aspirin on platelet adhesion to experimental autogenous vein grafts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Autoradiography; Carotid Arteries; Dipyridamole; Epoprostenol; Graft Occlusion, Vascular; Jugular Veins; Models, Biological; Platelet Adhesiveness; Rabbits | 1985 |
The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dipyridamole; Epoprostenol; Fibrinolytic Agents; Male; Prostaglandins; Rabbits; Thrombosis; Thromboxanes | 1983 |
Significance of myocardial prostaglandin biosynthesis and the influence of mechanical loading, endogenous mediators and cardiovascular drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Dipyridamole; Epoprostenol; Heart; Heart Atria; Heart Ventricles; Myocardium; Propranolol; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Thromboxane B2 | 1984 |
Dipyridamole interferes with the incorporation of arachidonic acid and stimulates prostacyclin production in rat lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Dipyridamole; Epoprostenol; Lipids; Lung; Male; Radioimmunoassay; Rats; Rats, Inbred Strains | 1983 |
Effects of diltiazem, dipyridamole, and their combination on hemostasis.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Adult; Benzazepines; Bleeding Time; Blood Pressure; Calcimycin; Diltiazem; Dipyridamole; Drug Therapy, Combination; Epinephrine; Heart Rate; Hemostasis; Humans; Male; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Thromboxane B2 | 1984 |
Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis Obliterans; Dipyridamole; Epoprostenol; Humans; Ischemia; Leg; Male; Middle Aged; Physical Exertion; Prostaglandins | 1981 |
Effect of dipyridamole on the formation of 6-oxo-prostaglandin F1 alpha by the rat isolated aorta and ram seminal vesicle microsomes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arachidonic Acids; Dipyridamole; Epoprostenol; In Vitro Techniques; Male; Microsomes; Rats; Rats, Inbred Strains; Seminal Vesicles; Sheep | 1982 |
The effect of platelet inhibitory therapy on graft thromboresistance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Pyridines; Radiography; Random Allocation; Thromboxane-A Synthase | 1993 |
Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Diabetes Mellitus, Experimental; Dipyridamole; Epoprostenol; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Retina; Streptozocin | 1997 |
Effect of dipyridamole on prostanoid production in rat isolated atria.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Diabetes Mellitus, Experimental; Dinoprostone; Dipyridamole; Epoprostenol; Female; Heart Atria; In Vitro Techniques; Insulin; Prostaglandins; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Vasodilator Agents | 1999 |